Saku, Japan

Kazuhiro Yamaura

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Kringle Pharma Inc.. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Yamaura. Retrieved from https://idiyas.com/inventor/kazuhiro-yamaura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuhiro Yamaura: Innovator in Organ Transplantation

Introduction

Kazuhiro Yamaura is a notable inventor based in Saku, Japan. He has made significant contributions to the field of organ transplantation through his innovative research and development. With a total of 3 patents, Yamaura is recognized for his advancements in medical technology.

Latest Patents

One of Yamaura's latest patents is a fibrosis inhibitor for implanted organs. This pharmaceutical preparation comprises a hepatocyte growth factor or a DNA molecule encoding the same. The invention aims to suppress the fibrosis of a transplanted organ after organ transplantation. This innovation is particularly useful in the fields of organ transplantation and regeneration therapy.

Career Highlights

Yamaura is currently associated with Kringle Pharma Inc., where he continues to work on groundbreaking solutions for organ transplantation. His research focuses on improving the outcomes of organ transplants and enhancing the quality of life for patients.

Collaborations

Yamaura has collaborated with notable colleagues, including Jun Amano and Ken-ichi Ito. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the medical field.

Conclusion

Kazuhiro Yamaura's work in organ transplantation exemplifies the impact of innovation in medicine. His patents and ongoing research are paving the way for improved transplant outcomes and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…